Title(s):
NRG-BN011 A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients With Methylated MGMT Promoter Glioblastoma (NCT 05095376)
Investigator(s): Daria Krivosheya, MD
Contact Information: McDowell Cancer Research 330.344.6348
